$3.45 -0.04 (-1.15%)
2/13/2012 12:33 PM

Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners


Advertisement